Clinical trials: Smoking-related Pathology
Emphysema
TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
This 2 arm study will investigate the efficacy, safety and tolerability of RAR Gamma versus placebo in ex-smokers with moderate or severe emphysema treated with optimal COPD therapy.
- Trial name
- NCT00413205
- Testing
- RAR Gamma
- Where
- 64 sites in United States, Bulgaria and 10 more
- Volunteers
- 491 people
- Sponsor
- Hoffmann-La Roche
Pulmonary Disease, Chronic Obstructive
Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.
Post marketing Surveillance to gain insights into the effects of therapy with Spiriva® (tiotropium bromide) on health-related quality of life in COPD patients who stopped smoking during treatment and to obtain safety data…
- Trial name
- NCT02172547
- Testing
- Spiriva
- Volunteers
- 10,821 people
- Sponsor
- Boehringer Ingelheim